| 嘉南藥理大學 |
2014-02 |
Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: A population-based cohort study
|
Lin, Charlene; Lin, Shih-Wei; Weng, Shih-Feng; Lin, Yung-Song |
| 臺北醫學大學 |
2014 |
Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: A population-based cohort study
|
Lin, C;SW, Lin;SF, Weng;YS, Lin |
| 臺北醫學大學 |
2013 |
Risk of Developing Sudden Sensorineural Hearing Loss in Patients with Nasopharyngeal Carcinoma: A Population-Based Cohort Study
|
Lin, C;SW, Lin;SF, Weng;YS, Lin |
| 臺北醫學大學 |
2014 |
Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: A population-based cohort study
|
Lin, C;Lin, SW;Weng, SF;Lin, YS |
| 臺北醫學大學 |
2013 |
Risk of Developing Sudden Sensorineural Hearing Loss in Patients with Nasopharyngeal Carcinoma: A Population-Based Cohort Study
|
Lin, C;Lin, SW;Weng, SF;Lin, YS |
| 國立成功大學 |
2015-12-01 |
Risk of Diabetes Mellitus after First-Attack Acute Pancreatitis: A National Population-Based Study
|
Shen, Hsiu-Nien; Yang, Chun-Chieh; Chang, Ya-Hui; Lu, Chin-Li; Li, Chung-Yi |
| 中國醫藥大學 |
2015-11 |
Risk of Diabetes Mellitus after First-Attack Acute Pancreatitis: A National Population-Based Study
|
沈修年(Hsiu-Nien Shen);(Chun-Chieh Yang);張雅惠(Ya-Hui Chang);(Chin-Li Lu);李中一(CHUNG-YI LI)* |
| 中國醫藥大學 |
2015-08 |
Risk of diabetes mellitus among patients with myasthenia gravis.
|
(J.-H. Yeh);陳宣如;林則成;(Y.-K. Chen);(H.-C. Chiu);高嘉鴻(Chia-Hung Kao)* |
| 國家衛生研究院 |
2018-09 |
Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study
|
Lin, SP;Wu, CY;Wang, CB;Li, TC;Ko, NY;Shi, ZY |
| 國立成功大學 |
2018 |
Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study
|
Lin, S.P.;Wu, C.-Y.;Wang, C.-B.;Li, T.-C.;Ko, N.-Y.;Shi, Z.-Y. |
| 國立成功大學 |
2019 |
Risk of diabetes mellitus in physicians: A nationwide study in Taiwan
|
Lee, S.-G.;Feng, I.-J.;Hsu, C.-C.;Wang, Y.-F.;Yang, C.-Y.;Wang, J.-J.;Chung, J.-Y.;Huang, C.-C. |
| 國立成功大學 |
2021-09 |
Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: A multi-institutional cohort study in Taiwan
|
Su;Yu-Chen;Shao;Shih-Chieh;Lai;Edward, Chia-Cheng;Lee;Chaw-Ning;Hung;Ming-Jui;Lai;Chi-Chun;Hsu;Sheng-Min;Hung;Jia-Horung |
| 國立成功大學 |
2021-09 |
Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: A multi-institutional cohort study in Taiwan
|
洪嘉鴻; Hung, Jia-Horung; Su, Yu-Chen;Shao, Shih-Chieh;Lai, Edward Chia-Cheng;Lee, Chaw-Ning;Hung, Ming-Jui;Lai, Chi-Chun;Hsu, Sheng-Min |
| 國立成功大學 |
2023 |
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
|
Lin, T.-Y.;Kang, E.Y.-C.;Shao, Shao S.-C.;Lai, E.C.-C.;Garg, S.J.;Chen, K.-J.;Kang, J.-H.;Wu, Wu W.-C.;Lai, C.-C.;Hwang, Y.-S. |
| 國立成功大學 |
2023 |
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
|
Lin, T.-Y.;Kang, E.Y.-C.;Shao, Shao S.-C.;Lai, E.C.-C.;Hwang, Y.-S. |
| 國立成功大學 |
2022-06-30 |
Risk of dialysis in patients receiving intravitreal anti-vascular endothelial growth factor treatment: a population-based cohort study
|
Yang;Shun-Fa;Su;Yu-Chen;Lim;Chen-Chee;Huang;Jing-Yang;Hsu;Sheng-Min;Wu;Li-Wha;Chang;Yi-Sheng;Hung;Jia-Horung |
| 國立成功大學 |
2022 |
Risk of dialysis in patients receiving intravitreal anti–vascular endothelial growth factor treatment: a population-based cohort study
|
Yang, S.-F.;Su, Y.-C.;Lim, C.-C.;Huang, J.-Y.;Hsu, S.-M.;Wu, L.-W.;Chang, Y.-S.;Hung, J.-H. |
| 臺大學術典藏 |
2020-09-30T03:22:19Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.;Sun H.-Y.;Cheng A.;Chuang Y.-C.;Huang Y.-S.;Lin K.-Y.;Huang Y.-C.;Liu W.-C.;Wu P.-Y.;Chien-Ching Hung;Chang S.-C.; Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2019 |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chang S.-C.; Hung C.-C.; Wu P.-Y.; Liu W.-C.; Huang Y.-C.; Lin K.-Y.; Huang Y.-S.; Chen G.-J.; Sun H.-Y.; Cheng A.; YU-CHUNG CHUANG |
| 臺大學術典藏 |
2020-12-29T05:33:46Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chuang Y.-C.; Cheng A.; HSIN-YUN SUN; Chen G.-J.; Hung C.-C.; Chang S.-C.; Wu P.-Y.; Liu W.-C.; Huang Y.-C.; Lin K.-Y.; Huang Y.-S. |
| 臺大學術典藏 |
2020-12-30T02:45:47Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Huang Y.-S.; Chuang Y.-C.; Sun H.-Y.; Cheng A.; Chen G.-J.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-08-24T08:23:32Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; YU-SHAN HUANG; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-27T06:48:51Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; KUAN-YIN LIN; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-16T08:36:16Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; ARISTINE CHENG; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-25T01:53:09Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; KUAN-YIN LIN; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
